Table 2.
Clinical characteristics of MS patients.
| MSr patients | MSs patients | p* | |
|---|---|---|---|
| Number of subjects, N | 60 | 30 | — |
| Duration of the disease (years) Mean ± SD |
8.94 ± 7.2 | 8.30 ± 7.5 | 0.697 |
| EDSS (in MSr during the 3rd month before the relapse) | 3.59 ± 1.3 (N = 49**) | 3.25 ± 1.19 | 0.243 |
| EDSS (in MSr during the 3rd month after the relapse) | 3.78 ± 1.26 | 3.25 ± 1.19 | 0.061 |
| The mean number of exacerbations | 4.82 ± 3.3 | 3.83 ± 2.4 | 0.108 |
| The period of remission (months) CI [lower-upper limit] |
23.22 ± 23.80 [17.07–29.37] |
30.2 ± 29.18 [19.31–41.10] |
0.228 |
| The duration of immuno-modulatory therapy (years) CI [lower-upper limit] |
3.40 ± 3.42 [2.49–4.31] |
3.33 ± 3.41 [2.06–4.61] |
0.931 |
MSr – relapsing MS patients, MSs – stable MS patients, EDSS – Expanded Disability Status Scale, CI – confidence interval.
*Student t-test.
**It was possible to assess the EDSS score retrospectively in 49 relapsing MS patients.